期刊论文详细信息
BMC Veterinary Research
Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model
Research Article
Zhenling Zeng1  Ying Qu1  Changfu Cao1  Zhenzhen Qiu1  Yan Lu1  Meizhen Sun1  Chaoping Liang1 
[1] National Reference Laboratory of Veterinary Drug Residues (SCAU), College of Veterinary Medicine, South China Agriculture University, Guangzhou, China;
关键词: Marbofloxacin;    Pharmacokinetics/Pharmacodynamics;    Pasteurella multocida;    Mouse-lung model;   
DOI  :  10.1186/s12917-015-0608-1
 received in 2015-04-21, accepted in 2015-11-24,  发布年份 2015
来源: Springer
PDF
【 摘 要 】

BackgroundMarbofloxacin is a third-generation fluoroquinolone developed solely for veterinary medicine with a broad spectrum of antibacterial activity against some Gram-positive and most Gram-negative bacteria, including the bovine respiratory tract pathogen, Pasteurella multocida. The objective of our study was to elucidate the pharmacokinetics and pharmacodynamics of marbofloxacin in a Pasteurella multocida infected murine lung model, and to estimate the magnitudes of pharmacokinetics-pharmacodynamics parameters associated with various effects.ResultsThe pharmacokinetic studies revealed marbofloxacin kinetics in infected mice were linear over a dose ranging from 1.25 to 10 mg/kg of body weight. The protein binding in the plasma of neutropenic infected mice was 29.77 %. The magnitudes of the ratio of the free-drug area under the concentration-time curve over 24 h to MIC (fAUC0-24h/MIC) associated with static effect, a 2 log10 reduction and a 3 log10 reduction of bacterial counts were 40.84, 139.34, and 278.08 h, respectively.ConclusionsBased on the dose range study, marbofloxacin exhibited concentration-dependent killing and the fAUC/MIC was the PK/PD index that correlated best with efficacy (R2 = 83 %). On the basis of a bactericidal effect goal of fAUC0-24h/MIC of 278.08 h, if marbofloxacin is used for the treatment of P. multocida serious lung infection with an MIC90 of 0.12 μg/ml, the current dose (2 mg/kg) would fail to achieve a bactericidal effect. It would benefit from higher doses (4 ~ 6 mg/kg) than those commonly used in clinical practice.

【 授权许可】

CC BY   
© Qu et al. 2015

【 预 览 】
附件列表
Files Size Format View
RO202311103498852ZK.pdf 653KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  文献评价指标  
  下载次数:17次 浏览次数:0次